Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes | Synapse
March 3, 2026Open Access
Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes
Key Points
Survivorship outcomes differ significantly, impacting treatment decisions and strategies.
Long-term survivors demonstrate distinct disease profiles compared to short-term counterparts.
Observational analysis across multiple cohorts highlights variations in systemic therapy responsiveness.
Findings underscore the importance of understanding patient-related factors in optimizing treatment.